Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8671762, 17 pages
http://dx.doi.org/10.1155/2016/8671762
Review Article

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk

1Unit of Endocrinology, Regina Elena National Cancer Institute, Rome, Italy
2Unit of Endocrinology, Department of Systems’ Medicine, University of Rome Tor Vergata, Section of Reproductive Endocrinology, Fatebenefratelli Hospital “San Giovanni Calibita” Rome, Italy
3Division of Medical Oncology B, Regina Elena National Cancer Institute, Rome, Italy
4Department of Gynaecologic Oncology, HPV-Unit, Regina Elena National Cancer Institute, Rome, Italy

Received 13 May 2016; Revised 12 July 2016; Accepted 8 August 2016

Academic Editor: Vittorio Unfer

Copyright © 2016 Rosa Lauretta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Maria A. Sortino, Salvatore Salomone, Michele O. Carruba, and Filippo Drago, “Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Dorte Glintborg, and Marianne Andersen, “Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: An updated review,” Current Opinion in Obstetrics and Gynecology, vol. 29, no. 6, pp. 390–396, 2017. View at Publisher · View at Google Scholar
  • Costanzo Moretti, and Giulia Lanzolla, “Uso dell’inositolo nella sindrome dell’ovaio policistico,” L'Endocrinologo, 2018. View at Publisher · View at Google Scholar